De-Individualizing fMRI Signals via Mahalanobis Whitening and Bures Geometry
Aaron Jacobson, Tingting Dan, Martin Styner, Guorong Wu, Shahar Kovalsky, Caroline Moosmueller
TL;DR
The paper tackles separating subject-specific from task-specific information in fMRI by applying Mahalanobis whitening to BOLD time series and evaluating the resulting data with distance-based, manifold-embedding approaches. It introduces a two-stage de-individualization workflow (mean removal followed by whitening with $W = \operatorname{cov}(\bar{S},\bar{S})$) and compares distances such as the Bures distance $d_B$ and the Frobenius distance $d_F$, with a preprocessing-informed distance $d_M$ guiding task clustering. Empirically, Bures-based embeddings recover subject identity, while the $d_M$-driven Isomap embedding reveals task-based patterns, with validation data confirming robustness to task ordering. The work offers interpretable preprocessing-driven tools for disentangling brain-behavior relationships and holds potential for biomarker discovery and improved diagnostic consistency in neurodegenerative contexts.
Abstract
Functional connectivity has been widely investigated to understand brain disease in clinical studies and imaging-based neuroscience, and analyzing changes in functional connectivity has proven to be valuable for understanding and computationally evaluating the effects on brain function caused by diseases or experimental stimuli. By using Mahalanobis data whitening prior to the use of dimensionality reduction algorithms, we are able to distill meaningful information from fMRI signals about subjects and the experimental stimuli used to prompt them. Furthermore, we offer an interpretation of Mahalanobis whitening as a two-stage de-individualization of data which is motivated by similarity as captured by the Bures distance, which is connected to quantum mechanics. These methods have potential to aid discoveries about the mechanisms that link brain function with cognition and behavior and may improve the accuracy and consistency of Alzheimer's diagnosis, especially in the preclinical stage of disease progression.
